| Trial registration number
|
NCT05274685 |
Full text link
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05274685
|
First author
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
2022-03-10
|
Recruitment status
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
inclusion criteria:
adult patients (≥18 years old) with confirmed severe acute respiratory syndrome coronavirus 2 infections admitted to the icu.
|
Exclusion criteria
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
•malignancy.
immuno-deficiency diseases.
chronic diabetic, cardiac and hypertensive patients
autoimmune diseases.
|
Number of arms
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Sohag University
|
Inclusion age min
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Critical disease at enrollment
|
Severity scale
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
8: Critical disease at enrollment
|
Total sample size
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
100
|
primary outcome
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
reduction of Sequential Organ Failure Assessment Score
|
Notes
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : March 12, 2022, midnight
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 495, "treatment_name": "Hemodialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 495, "treatment_name": "Hemodialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}]
|